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The I region of the mouse H-2 complex was originally recognized because of the role it 
plays in the regulation of  the immune response to thymus-dependent antigens (1). Later, 
the region was shown also to code for antigens capable of stimulating (a) T lymphocytes 
in the mixed lymphocyte reaction (cf. 2, 3) and in the graft-vs.-host reaction (cf. 4, 5), and 
(b) B lymphocytes toward the production of serelogically detectable Ia antibodies (6, 7, 
and others). The/-region controlled antigens, however, were claimed to be incapable of 
stimulating  the  production  of cytotexic effector T  cells  (8)  and,  therefore, to  differ 
fundamentally from antigens  controlled by the K  and D  regions.  The first finding 
contradicting the distinction of the I  and K(D) regions, with respect to their capacity to 
generate T-effector cells, was the observation that/-region antigens can cause rapid 
rejection of skin grat~s (9) and that lymphocytes obtained from mice after rejection of  such 
grafts are  capable of killing  mitogen-stimulated blasts  in the  in vitro cell-mediated 
lymphocytotoxicity (CML) 1 assay  (10).  The latter observation recently has been con- 
firmed and extended by several laboratories (11, 12). 
In the meantime, data have been accumulated indicating genetic complexity of the I 
region and the division of this region into subregions (reviewed in reference 13). How 
many of these subregions actually exist is at present uncertain. Two subregions, IA and 
IC, have been defined by several criteria, and their existence can, therefore, be consid- 
ered as firmly established. A third subregion, IB, has been defined by its capability to 
regulate the immune response to myeloma proteins (14), LDH~ (15), and staphylococcal 
nuclease (16); it was also claimed to control Ia antigens (17), but recently that claim has 
been withdrawn (18). The definition of the IB subregion is based on the typing of a single 
H-2 recombinant, H-2  h4, and on the assumption that this recombinant was derived by a 
single, equal crossing-over event. Should the latter assumption prove to be incorrect, the 
IB subregion would cease to exist. In addition to IA, IB, and IC, the existence of other 
subregions has been claimed by several laboratories (19-22) with little data to support 
such claims. Although numerous I subregions may exist, the available data do not allow 
the definition of more than two or possibly three subregions. 
The division of the I  region into subregions,  most likely containing distinct 
genetic loci, raises the question of  the participation of different subregions in the 
production  of effector T  cells  and  the  relationship  of the/-region-associated 
* This work was supported  by grants AI 11650, AI 12589, and CA 17225 from the National 
Institutes of Health. 
1  Abbreviations used in this paper: CML, cell-mediated lymphocytexicity; Con A, concanavalin 
A; FCS, fetal calf serum; HBSS, Hanks' balanced salt solution; LPS, lipopolysaccharide; TNP, 
trinitrophenyl. 
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histocompatibility  (H) antigens to the serologically-detectable Ia antigens.  In 
this communication, we map a strong H locus into the IA subregion and a weak 
H locus into theIC subregion. In addition, we present some evidence suggesting 
that the H and the Ia determinants may be coded for by the same loci. 
Materials and Methods 
Mice.  The mouse strains used in the present study are listed in Table I. They were all bred and 
produced in our colony originally at the University of Michigan, Ann Arbor, Mich. and now at the 
University of Texas Southwestern Medical School. 
Skin Grafting.  The majority of skin grafts were taken from tail and placed in the dorsolateral 
region of sex-matched recipients, following the technique described elsewhere (23). Bandages were 
removed between 7 and 9 days after grafting, and the grafts were inspected daily for the first 4 wk 
and once a  week thereafter. In a  few instances, the tail-to-tail grafting technique of Bailey and 
Usama (24) was used. 
Cytotoxic Test.  The presence of cytotoxic antibodies was determined using the micrecytotoxic 
test described elsewhere (9). Either a  mixture of 3:1 normal guinea pig serum and normal rabbit 
serum, or normal guinea pig serum alone, was used as a  source of complement. The target cells 
were either splenocytes or epidermal cells. 
Preparation of Epidermal Cells.  The donor was killed by cervical dislocation, the hair on the 
abdomen and thorax was removed with clippers,  and the mouse was dipped in 70%  aqueous 
alcohol.  Large  pieces of skin were  cut  from the  abdomen  and thorax  and minced into  small 
fragments which were then incubated with gentle agitation by a  magnetic stirrer for 30 rain at 
room temperature in 50 ml of 0.25% trypsin (made in Ca  ++- and Mg++-free Hanks' balanced salt 
solution,  HBSS, pH adjusted to 6.8-6.9).  The supernate was decanted, and the remaining tissue 
was incubated three more times with fresh trypsin solution.  The cells  from the third and fourth 
decanted cell  suspensions were concentrated by centrifugation at 220 g for 10 rain, and then 
resuspended in  HBSS containing 20% fetal  calf  sernm (FCS). The suspension was filtered  through 
a 20-ml  syringe containing Leukopak fibers  lightly  dry-packed into  a layer  4-  to  5-ram thick.  Live 
cells  were counted, resuspended in  HBSS-FCS, incubated for  90  rain  at  37°C,  and  then used in  the 
cytotoxic test. 
CML Assay.  The CML assay was performed as described elsewhere (25).  We used concana- 
valin A  (ConA)- or lipopolysaccharide (LPS)-stimulated blasts as target cells. Since we found no 
difference in the degree of lysis of these two targets, we pooled the data from the corresponding 
experiments. 
Results 
Genetic  Homogeneity  of Strains  Used.  For  the  types  of experiments  de- 
scribed  below,  it  is  imperative  to  establish  beforehand  that  any  rejections 
observed are not caused by residual heterozygosity of the mouse lines used. For 
this reason, we randomly selected 10 sex-matched mice of each of the critical 7 
strains (A.TL, A.TH, B10.AQR, 6R, 7R, 9R, and B10.HT1  ~) and exchanged skin 
grafts between the individual animals in the manner of  the reciprocal circle (26). 
None  of the  grafts  was rejected during  the  observation  period  of 100  days, 
indicating that no histocompatibility loci were segregating in the seven lines. 
Background Identity.  Another important criterion that has to be satisfied 
before  a  genetic  study  of histocompatibility  requirements  can  begin  is  the 
background identity of congenic lines used. To determine whether the congenic 
lines do indeed differ only in the H-2  complex,  as expected, the following F1 
hybrid tests were performed: A -* (A.TL x  B10.A)FI, A --* (A.TH ×  B10.A)F1, 
B10.BR--,  (7R  ×  C3H)F1, B10.BR-,  (9R  ×  C3H)F~, B10.BR--*  (B10.HTT  × 
C3H)F~, B10.A--, (6R × A)F~, and B10.A--, (B10.AQR × A)F~. In each of these 
seven strain combinations, one parent of the F~ hybrid provided the H-2 haplo- J.  KLEIN,  R.  GEIB,  C.  CHIANG,  AND  V.  HAUPTFELD 
TABLE I 
Mouse Strains Used 
Strain  Abbreviation  H-2 haplotype 
B10.A  a 
C57BL/10Sn  B10  b 
B10.D2  d 
B10.M  f 
D2.GD  g2 
B10.A(2R)  2R  h2 
B10.A(4R)  4R  h4 
C3H/HeJ  C3H  k 
CBA/J  CBA  k 
B10.BR  k 
C3H.OL  ol 
C3H.NB  p 
B10.Q  q 
B10.S  s 
A.TL  tl 
A.TH  t2 
B10.S(7R)  7R  t2 
B10.HTT  t3 
B10.S(9R)  9R  t4 
B10.AQR  yl 
B10.T(6R)  6R  y2 
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type and the other the rest of the genome of the donor strain. Therefore, if, 
indeed, the seven tested congenic lines were to have the genome of either the A 
strain (lines A.TH and A.TL) or the B10 strain (the remaining 5 lines), grafts 
transplanted in these combinations should have survived permanently. 7-12 
sex-matched mice in each of the seven strain combinations were grafted with 
tail skin. In six of the seven combinations no rejections occurred during the 100- 
day observation period; in one combination [B10.A -* (B10.AQR x  A)F1], five 
grafl~ survived for over 100 days, whereas two grafts were rejected, one 73 and 
the other 85 days after transplantation. We conclude from these experiments 
that six of the seven tested congenic lines do not differ in any minor  H  loci from 
their inbred partners; the seventh line (B10.AQR) appears weakly histeincom- 
patible  with  its  inbred partner.  The  weak  residual  histoincompatibility of 
B10.AQR, however, did not interfere with the type of experiments described 
herein. 
Mapping of the Strong 1-Region Histocompatibility Locus.  Once we estab- 
lished the genetic homogeneity and cengenicity of the critical mouse lines, we 
attempted to map within the I  region the strong H  locus which we described 
previously (9). Summary of the mapping data is given in Table II. The first four 
strain combinations listed in this table confirm the presence of the strong I- 
region-associated H  locus in four additional H-2 haplotypes (t/, t2, yl, andy2). 
In pairs of congenic lines carrying these haplotypes and differing in central H-2 
regions, all exchanged skin grafts were rejected within 3 wk after grafting. The 
remaining two strain combinations in Table II map the strong H locus in the 1.4 
subregion. Since no strain combination differing only at the IA  subregion is 
available, the mapping had to be indirect. It was based on comparing two strain 1442  HISTOCOMPATIBILITY  ANTIGENS 
TABLE II 
Survival of Skin Grafts Transplanted Across Central H-2 Region Barriers: Differences 
Involving the IA Subregion 
Donor  Recipient 
BI0.AQR  6R 
6R  B10.AQR 
A.TH  A.TL 
A.TL  A.TH 
B10.AQR  (B10.Q  ×  B10.D2)F, 
H-2 region  difference 
Sex  Response  R/T* 
GraR  survival 
K  A  B  C  S  G  D  T  MST-+SD*  Range 
2  1  °  -  k  k  d  d  d  10/10  12.8  -+ 0.9  11-16 
1 °  -  k  k  d  d  d  5/5  15.2  -+ 2.3  12-22 
9  2 °  -  k  k  d  d  d  7/7  8.3-0.3  6-9 
1  °  -  q  q  q  q  q  16/16  13.2  ±  1.0  11-17 
1  °  -  q  q  q  q  q  -  10/10  14.1  ±  1.O  12-19 
2 °  -  q  q  q  q  q  12/12  8.4  -+  0.4  6-9 
1 °  -  s  s  s  s  s  -  a  12/12  13.1  -+  1.2  11-16 
c~  1  °  -  s  s  s  s  s  -  a  10/10  13.8  -+  1.5  11-18 
9  2 °  -  s  s  s  s  s  -  a  8/8  8.0  -+  0.6  7-9 
1  °  -  k  k  k  k  k  -  c  8/8  13.3  -+  1.5  11-17 
6  1 °  -  k  h  k  h  h  -  c  7/7  14.1  -+  0.9  12-16 
2 °  -  k  h  k  k  h  -  c  5/5  7.9  ~  0.5  6-8 
1 °  --  k  k  ....  a  7/7  12.1  -+  1.1  10-15 
1  °  -  k  k  a  5/5  13.5  _+ 2.5  12-17 
2 °  -  k  k  -  a  7/7  7.5  -+  0.7  6-9 
B10.A  (4R  x  B10.D2)F,  ?  1 °  -  -  k  ....  a  3/5  37.3  -+  7.3  28-52 
6  1 °  -  -  k  ....  a  4/4  36.8  ±  6.4  28-52 
*  Number  of mice  that  rejected  grafts/number  of transplanted  mice. 
*  Median  survival  time  _+  standard  deviation. 
combinations, one differing inIA  + IB subregions and the other differing in the 
IB subregion only. In the former strain combination, all skin grafts were rapidly 
rejected (within 3 wk after transplantation); in the latter combination, two out 
of nine grafts survived for more than 80 days, while the remaining grafts were 
rejected but in a delayed and chronic fashion, indicating the presence of only a 
weak H  barrier.  Since  in this strain combination the donor differs from the 
recipient also in the T region which is known to be associated with weak H  loci 
(27), we consider it likely that the observed minor histoincompatibility is caused 
by the T  region loci.  We conclude, therefore,  that the rapid rejection  of skin 
allografts is associated with the IA subregion. 
Mapping  of the  Weak  I-Region  Histocompatibility  Locus.  Table  HI  lists 
eight donor-recipient combinations that are genetically compatible at K, D, and 
A  regions but incompatible at C, S, and G regions; six of these combinations are 
also incompatible at the T  region.  In all eight combinations, skin-graft rejec- 
tions were observed. Depending on the particular combination, the proportion of 
rejected gral~ varied from between 30 and 100%. Although some of the first-set 
grafts were rejected as early as 2 wk after tranplantation, the rejection of the 
majority of grafts was delayed for a month or longer. Frequently, the rejection 
process was protracted over a period of several weeks. Some grafts that were 
never rejected,  nevertheless,  underwent a "cosmetic crisis" characterized by a 
temporary loss of hair crop and scaliness. The crisis lasted from 1 to 2 wk, but 
then  the  grafts  recovered  and  remained  healthy  for  the  remainder  of the 
observation period. After rejection of first-set grafts, recipients were regrafted 
with skin from the same donor strain.  Majority of the second-set grafts were 
rejected in an accelerated manner, although, again, some grafts survived for the J.  KLEIN,  R.  GEIB,  C.  CHIANG,  AND  V.  HAUPTFELD  1443 
TABLE  I~ 
Survival of Skin Grafts Transplanted Across Central H-2 Region Barriers: Differences 
Involving the IC Subregion 
H-2-re~on difference 
Donor  Recipient  Sex  Response  R/T* 
Behavior  of grafts 
K  A  B  C  S  G  D  T  Grafts  rejected  Grafts  surviving 





9R  B10.I-ITr 
9R  J  1 °  -  -  s  s  s  3/11  73, 84, 87  35, 48,56,100(Sx) 
2 °  -  -  s  s  #  3/3  25, 30, 32 
7R  ~  1  °  -  -  -  d  d  d  3/10  20, 25, 48  60, 78,  100(5×) 
c~  1  °  -  -  -  d  d  d  2/13  28, 63  54,  100(9×) 
2 °  -  -  d  d  d  5/7  15, 22, 23, 23, 28  50, 50 
B10.HTT  ~  1  °  -  -  s  s  s  -  a  10/15  15,  19,  19,  22,  26,  50, 50, 65, 90,  120 
32, 34, 36, 36, 80 
2 °  -  -  s  s  s  -  a  8/9  9,10,10,12,12,12,  90 
16, 20 
7R  ~  1  °  -  -  -  k  k  k  -  c  5/5  14, 26, 36, 38, 39 
2 °  -  -  -  k  k  k  -  c  22/22  9(2x),  10(gx),  11, 
12(3x),  13,  14, 
15(2×),  16,  17, 
20 
1 °  -  -  -  d  d  d  -  a  8/8  17,  18,  25,  25,  31, 
35, 38, 55 
c~  1 °  -  -  -  d  d  d  -  a  6/6  17,  21,  19,  19,  19, 
32 
~P  2 °  -  -  -  d  d  d  -  a  6/6  8,  8,  12,  14,  14,  15 
c~  2 °  -  -  -  d  d  d  -  a  6/6  11,  11,  14,  15,  22, 
22 
B10.H'Pr  9R  1 °  k  k  k  -  c  8/8  17,  18(3×),  19,  20, 
25, 29 
?  2 °  -  -  k  k  k  -  c  8/8  10, ll(2x),  12(4x), 
13 
A.TL  (A.TH x  ~  1  °  k  k  k  -  c  1/3  13  127, 127 
2R)F~  6  1  °  k  k  k  -  c  3/6  35, 38, 40  127, 127, 127 
A.TL  (A.TH  ~  1  °  k  k  k  -  c  1/3  48  122, 122 
×  4R)F~  c~  2 °  k  k  k  -  c  3/11  11,  17, 45  122(8×) 
c~  2 °  k  k  k  -  c  3/3  15,  17,  19 
C3H.OL  (D2.GD  @  2 °  d  4/7  17, 23, 28, 30  55, 55 
x  C3H)F, 
* Number  of mice that rejected grafts/number  of  grafted mice. 
entire  observation  period.  This  behavior of  skin grafts  is  characteristic  of  weak 
histocompatibility  barriers  and thus indicates  that the tested  donor-recipient 
combinations differ  at minor H  loci.  In six of the tested  combinations, the 
rejections  might have been caused  by genetic  differences  at  the  T region which 
previously has been demonstrated to contain minor H  loci  (27).  In the two 
reciprocal  7R ~  9R combinations, however, no difference  at the T region was 
present, and yet the skin grafts  were rejected.  This result  suggests that the 
portion  of  the  H-2 complex  to  the right  of  IA and to  the left  olD also  contains  a 
minor  H  locus.  To  map this  locus  further,  we graitod  C3H.OL skin  on (D2.GD x 
C3H)FI hybrids.  In  this  combination, the  donor  differs  from  the  recipient  only  in 
the  IC subregion. The rejection  of  skin grafts  in this  strain  combination indi- 
cates  that it  is  the  IC subregion that contains  the minor  H  locus. 
The Involvement of the I Region in CML.  To test whether antigens coded for 1444  HISTOCOMPATIBILITY  ANTIGENS 
by the  IA and  IC subregions can also  function  as targets  in the in vitro  CML 
assay,  we took some of  the mice that rejected  their  skin grafts,  restimulated 
their  spleen  cells  in  vitro  with the donor  cells,  and then  tested  the effector  cells 
against 51Cr-labeled  target  cells  (Con A  or LPS blasts  derived from donor 
lymphocytes). Most combinations were tested in three to four independent 
experiments with at least  three replicas  per each combination and with three 
effector.target  cell  ratios  (50:1,  25:1,  and 12:1).  A typical  experiment  is  shown in 
Fig.  1, and the data are summarized in  Table IV. 
In all combinations differing  at the IA subregion, strong lympholysis was 
observed (see also reference 10); in all combinations differing in IB, IC, S, G, 
and T subregions, much weaker lympholysis was obtained, indicating that the 
strong killing was directed against antigens controlled by the IA  subregion. 
Particularly  informative  in  this  respect  are  the  combinations  (B10.Q  x 
B10.D2)F1 anti-B10.AQR and (4R x  B10.D2)F1 anti-B10.A. The weak lymphol- 
ysis observed in these two combinations was most likely directed against IC 
antigens (former combination) or T antigens (latter combination). 
In all  combinations differing at the IC  subregion, a  weak but significant 
killing was observed. In combinations 7R ~  B10.HTT and 9R ~  B10.HTT, this 
killing could have been caused by antigens ceded for by S  or G regions; but in 
the (D2.GD  x  C3H)F1 anti-C3H.OL combination, the killing must have been 
directed against antigens of the IC subregion. We conclude, therefore, that IC- 
subregion antigens can function as targets in the CML assay. 
To determine the nature of the killer cells responsible for the CML in these 
combinations, we exposed the effector cell suspension, before mixing it with 
target cells, to an AKR anti-C3H (anti-Thy-l.1) serum (dilution 1:5), incubated 
the cells for 30 rain at room temperature, washed the suspension three times, 
incubated the cells with a 3:1 mixture of normal guinea pig and rabbit sera (as a 
source of complement), then incubated the cells for additional 30 rain at room 
temperature, washed, and then resnspended them to the desired concentration. 
The treatment  almost completely abolished the  lympholytic capacity of the 
effector cell suspension (Fig. 2), indicating that the killer cells in this assay were 
T lymphocytes. 
Production of  la ,Antibodies in Skin-Grafted Mice.  Some of the animals that 
received second- or third-set skin grafts in strain combinations listed in Table HI 
were bled once a week for 8 wk and their sera individually tested in the cytotoxic 
test against spleen cells of  the proper  1-1-2 haplotype. In two strain combinations, 
7R anti-B10.HTT and (A.TH  x  4R)F~ anti-A.TL, antibodies were found in the 
recipients'  sera (Table V). The antibodies appeared early  after  the second 
grafting  (within  2  wk) and  often  persisted  for  at  least  8  wk. The  positive  antisera 
were pooled,  and the pools  were then used for additional  tests.  Both antisera 
killed  only about 60% of  unfractionated  spleen cells,  almost 100 percent of  B 
lymphocytes, but  almost  no  T lymphocytes (Fig.  2),  suggesting  that  the  antibod- 
ies they contained were directed against la antigens. This suggestion was 
confirmed by testing the pooled antisera against a panel of 1-1-2 congenic lines 
andH-2 recombinants (Table VI). The reactivity pattern of  these antisora can be 
best explained by assuming that they are directed against antigens coded for by 
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FIG.  1.  The effect of effector-cell pretreatment with anti-Thy-1 serum and complement. 
(O-- -O) 9R  (responder, untreated)-7R (stimulator)-9R (target); (A__ .A) 9R  (responder, 
treated)-7R (stimulator)-9R (target); (O-Q)  7R (responder, untreated)-gR (stimulator)-9R 
(target); (A-  A) 7R (responder, treated)-9R (stimulator)-9R (target). 
TABLE  IV 
Cell-Mediated  Lysis in Strain Combinations Involving the IA and IC Subregions 
Responder*  Stimulator  Target 
H-2 region differences  Mean per-  Mean net 
cent release  release of 
K  A  B  C  S  G  D  T  °fs~Cr -+  s~Cr 
SE§ 
B10.AQR  6R  B10.AQR  35.9  -+ 
6R  B10.AQR  B10.AQR  -  k  k  d  d  d  58.0  -+ 
6R  B10.AQR  6R  37.4  _+ 
B10.AQR  6R  6R  -  q  q  q  q  q  62.7-+ 
B10.AQR  (B10.Q  ×  B10.D2)F1  B10.AQR  39.5  -+ 
(B10.Q  x  B10.D2)F1  B10.AQR  B10.AQR  -  k  k  a  62.1  -+ 
B10.A  (4R  x  B10.D2)FI  B10.A  31.3  -+ 
(4R  × B10.D2)F1  B10.A  B10.A  k  a  38.2  -+ 
7R  9R  7R  35.6  -+ 
9R  7R  7R  s  s  s  47.4  -+ 
9R  7R  9R  31.8  -+ 
7R  9R  9R  d  d  d  44.6-+ 
B10.HTr  7R  B10.HTT  41.4  -+ 
7R  BlO.I-rPr  B10.HTT  k  k  k  -  c  56.3  -+ 
7R  B10.HTr  7R  38.9  -+ 
B10.HTT  7R  7R  s  s  s  -  d  54.5  _+ 
9R  B10.HTT  9R  29.9  -+ 
B10.I-ITr  9R  9R  d  d  d  -  a  42.2  -+ 
B10.HTr  9R  B10.HTr  41.4  _+ 
9R  B10.HTr  B10.HTT  k  k  k  -  c  54.7  _+ 
C3H.OL  (D2.GD  x  C3H)F1  C3H.OL  33.4  _+ 
(D2.GD  × C3H)F]  C3H.OL  C3H.OL  d  43.9  _+ 
% 
3.1 
3.9  22.1 
3.2 
4.1  25.3 
3.9 
4.2  22.6 
1.5 
1.9  6.9 
3.2 
3.3  11.8 
2.5 
1.6  12.8 
1.3 
1.9  15.2 
3.6 
3.9  14.6 
1.5 
3.1  12.3 
2.4 
2.9  13.3 
3.1 
2.8  10.5 
* In all combinations the responding cells were obtained from a mouse that previously rejected a skin 
strain used as the source of stimulating  cells. 
Theoretically, the effector cells can react against products of the indicated regions. 
§ Effector.target cell ratio 50:1. The percent release of isotope was calculated according to the formula: 
(cpm supernate -  background) x  2 
Percent release ofsICr =  x  I00 
(cpm supernate +  pellet) -  2 x  background 
graR from the 
Presence of  IaC Antigens on Epidermal Cells.  The antisera produced by skin 
grafting reacted in the cytotoxic test against CBA epidermal cells (Fig. 2; only 
data for the 7R anti-B10.HTT serum are shown). Absorption of the antisera by 
CBA spleen cells removed this reactivity, and absorption by equal number of 
CBA epidermal cells significantly reduced their reactivity against CBA spleen 1446  HISTOCOMPATIBILITY  ANTIGENS 
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FIG.  2.  Titration  in the cytotoxic  test  of  antiserum produced by grafting of  7R mice with 
B10.HTT skin. (O-O) C3H spleen cells;  (A--A) CBA epidermal cells;  (A-A) C3H B cells; 
(©-O) B10.S spleen cells;  (D-D) C3H T cells. 
TABLE  V 
Reactivity in the Cytotoxic Test of Sera from Mice Transplanted with Skin Grafts 
Mouse no. 
Reciprocal of titre* at days after transplantation 
14  21  28  35  42  49  56 
7Ranti-B10.HTT 
1  (4)$  32  32  8  4  2  0 
2  0  (0)  0  0  0  0  0 
3  (8)  8  4  0  0  0  0 
4  (0)  128  128  32  32  32 
5  0  0  0  0  0  0  0 
6  (32)  32  64  8  4  4  4 
7  0  0  0  0  0  0  0 
8  (128)  128  128  64  64  32  4 
9  (16)  16  8  4  0  0 
(A.TH x 4R)FI anti-A.TL 
1  0  0  0  0  (0)§  0  0 
2  0  (0)  8  8  2  0  0 
3  0  (8)  8  8  8  4  4 
4  0  0  0  0  0  (0)§  0 
5  32  (64)  64  32  4  4  4 
* Titre corresponds to the last serum dilution displaying above-background reactivity against 
CBA spleen cells (background varied between 10 and 20%). 
* Parentheses indicate approximate time of second- or third-set graft rejection. 
§ First-set grafts; all other grains were of the second-set type. 
cells (Fig. 3; again, only data for the 7R anti-B10.HTT serum are shown). These 
results indicate the presence on epidermal cells of Ia antigens controlled by the 
IC subregion. 
Discussion 
The data presented in this communication indicate that the I region of the H-2 
complex contains at least two H  loci: a strong H  locus in the IA subregion and a 
weak locus in the IC subregion. In an earlier communication (9), we designated J.  KLEIN,  R.  GEIB,  C.  CHIANG,  AND  V.  HAUPTFELD 
TABLE VI 
Reactivity in the Cytotoxic Test of  Pooled Sera from Mice Transplanted with 
Skin Grafts 
1447 
Test cells  Reciprocal of titre* with antiserum 
Strain  H-2 haplotype  K-477*  K-5175 
B10.A  a  0  0 
A.TFR5  ap5  0  0 
B10  b  O  0 
B10.D2  d  32  0 
B10.M  f  32  0 
B10.BR  k  64  16 
C3H.NB  p  32  0 
B10.Q  q  0  0 
B10.S  s  0  0 
A. TL  tl  32  32 
A.TH  t2  0  0 
B10.HTr  t3  62  16 
B10.AQR  yl  0  0 
6R  y2  0  0 
* Titre corresponds to  the last  serum dilution  displaying above-background 
ity against the indicated cells  (background varied between 10 and 20%). 
* K-477: 7R anti-B10.HTT; K-517: (A.TH x 4R)FI anti-A.TL. 
reactiv- 
the strong locus asH-2I, but in view of  the mapping data presented here, a more 
proper designation is H-2IA  or simply H-2A.  The weak H  locus can then be 
designated as H-2IC  or H-2C.  The localization of the H-2A  locus in the IA 
subregion is based on the result of skin grafting in two swain combinations: the 
rapid rejection of B10.AQR grafts placed on (B10.Q  x  B10.D2)F1  recipients 
(donor-recipient difference atIA  + IB  + T regions) and slow rejection of B10.A 
grafts on  (4R  ×  B10.D2)F1  recipients  (donor-recipient difference at IB  +  T 
regions). However, indirectly this mapping is supported by several additional 
combinations in which the donor differs from the recipient at all central H-2 
regions except IA and in which the grafts are rejected slowly (Table HI). Thus 
the position of the H-2A locus in the IA subregion is relatively well established. 
The mapping of the H-2C locus in the IC subregion is based on the rejection of 
C3H.OL grafts placed on (D2.GD x  C3H)F~ hybrids (donor-recipient difference 
at theIC subregion only). However, this mapping, too, is supported  by rejections 
in additional combinations in which the difference is in theIC, S, and G regions. 
In previous tests (28), we found no evidence for the S or G regions causing graft 
rejections and we  assume,  therefore,  that  in  these IC  +  S  +  G-disparate 
combinations, the rejections are caused byIC-region antigens. Rejections of skin 
grai~ in IC  +  S  +  G-disparate combinations was also observed by Stimpfling  2 
and McKenzie and Henning (29). 
The H-2A locus causes skin graft rejection within 3 wk (this communication) 
and heart-muscle rejection within 5 wk after transplantation.  3 Furthermore, the 
2  Stimpfling,  J. H. 1971.  Presentation at  the  Workshop on  theH-2 complex, Bar Harbor, Maine. 
3  Klein, J., C. Chiang, J. Lofgreen, D. Steinmuller. 1976.  Participation  of  H-2 regions in hear~ 
transplant rejection.  Submitted for publication. 1448  HISTOCOMPATIBILITY ANTIGENS 
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FIG.  3.  Absorption of 7R anti-B10.HTT serum with CBA spleen and epidermal cells. (O- 
e) unabsorbed antiserum; (A_ L~) antiserum absorbed by epidermal cells; (O- O) antise- 
rum absorbed by spleen cells.  Antisera were absorbed by incubating them three times 
(spleen cells) and six times (epidermal cells) with equal volume of  packed cells, each time 30 
min at 37°C. 
locus is apparently also responsible for rapid rejection of  I-region-imcompatible 
lymphomas (30) and mammary adenocarcinomas (30 and J. Klein, unpublished 
data). Therefore, with regard to its strength, the locus is comparable to the H- 
2K  or H-2D  loci  residing in  the K  and D  regions,  respectively.  Testing of 
different H-2 haplotypes indicated that at least four alleles exist at this locus, 
and there is every reason to believe that the locus is as polymorphic as the H-2K 
and H-2D loci. Antigens coded for by the H-2A locus serve as the targets in the 
in vitro CML assay when the assay is performed under optimal culture condi- 
tions (11, 12) or when spleens from in vivo presensitized animals are used as 
source of effector cells (10 and this communication). The mechanism of the IA- 
region killing in the CML assay is still under study, but the data available thus 
far indicate that the killing is mediated by T  cells  (12) and that it does not 
require K-  or D-region compatibility (J.  Klein and C.  Chiang, unpublished 
data). This latter property distinguishes the H-2A antigens from all minor H 
antigens which have been shown by Bevan (31) to serve as targets in CML only 
when the target cell shares with the stimulating cell the same allele at either 
the H-2K or the H-2D locus. In this respect the H-2A locus is an equal partner to 
the H-2K andH-2D loci. In fact, the only major characteristic in which the H-2A 
locus differs from the H-2K and H-2D loci is its failure to mediate syngeneic 
lymphocytotoxicity against virus-infected or haptenated cells. Blanden et al. 
(32) reported that effector cells generated against syngeneic cells infected with 
the lymphocytic choriomeningitis or vaccinia virus will lyse virus-infected tar- 
get cells in vitro, provided that the responding (and the stimulating) cell shares 
with the target cell either the K  or the D  region; sharing of I  region is not 
sufficient to mediate the lympholysis. Similarly, Shearer et al. (33) and Forman 
(34) observed that sharing of K  or D  regions is necessary for lympholysis of 
trinitrophenyl (TNP)-modified target cells by effector cells generated against 
TNP-modified stimulating cells. Here again, sharing of the I  region does not 
suffice for the lympholysis to occur. However, one should bear in mind that 
reproducible demonstration of allogeneic CML  across  the I  region requires 
optimization of the culture conditions and it is,  therefore, still possible that 
similar optimization will also be required for the demonstration of syngeneic J.  KLEIN,  R.  GEIB,  C.  CHIANG,  AND  V.  HAUPTFELD  1449 
CML against neoantigens. At the time of this writing the problem of syngeneic 
I-region CML certainly must be considered as open to further investigation. 
The Ho2C locus is extremely  weak and must, therefore, be classified as minor. 
Some first-set skin grat~s transplanted across H-2C barriers remained healthy 
for at least 100 days, while others were rejected within this period of time. The 
rejection times range from between 14 and more than 80 days after grafting. The 
rejection process across H-2C barriers is protracted and often lasts for several 
weeks.  Most  second-set skin  grat~s  are  rejected in  an  accelerated manner. 
Whether the locus can cause rejection of grai~ from tissues other than skin is 
not known. 
By using in vivo sensitized mice as a source of effector cells, and by restimu- 
lating the effector cells in vitro, we were able to establish that the antigens 
coded for by the H-2C locus can also function as targets in the in vitro CML 
assay. Nabholz et al. (12) observed lympholysis by cells primed in vitro against 
antigens controlled by the right~hand portion of the central H-2 segment. They 
suggested that the killing they observed was directed against antigens coded for 
by the IC subregion, but, in fact, the strain combinations that they tested also 
differed in  the S,  G,  and  T  regions,  and  the  authors did  not exclude the 
possibility that the observed lympholysis might have been caused by these three 
regions. The observation of positive CML in the strain combination (D2.GD  × 
C3H)F1 anti-C3H.OL (Table IV) is thus the first unequivocal demonstration that 
IC antigens serve as targets in the CML assay. The critical question now is 
whether the IC lympholysis required compatibility at the K or the D region, in 
the same way as all minor H  loci do (31). Experiments to answer this question 
are in progress. If it, indeed, turns out that IC killing were not to occur in K-D 
incompatible combinations, then the H-2C locus will have to be considered as 
another member of the growing family of minor H  loci. Some 40 such loci have 
been identified in the mouse (13), and Bailey (35) has predicted that several 
hundreds of these loci may actually exist. Since minor  H loci are distributed all 
over the mouse genome, it would not be surprising to find some of them within 
the H-2 complex. On the other hand, if it were to turn out that the IC killing 
does not require K-D compatibility, as is the case of the H-2A  locus, one will 
have to postulate that the I-regionH loci differ from minor  H loci in some special 
intrinsic properties. 
The relationship of the H-2A and H-2C loci to the Ia loci is not clear. Three 
observations can be interpreted as indicating that the Ia products themselves 
may function as transplantation antigens. The first observation is that skin (9), 
heart,  3 and tumor (J.  Klein,  unpublished data)  graft rejection across the I- 
region barrier is accompanied by the production of Ia antibodies. This produc- 
tion is particularly evident after grafting across/A-subregion differences. We 
found Ia antibodies in all/A-disparate combinations tested, usually after first- 
set gaining and around the time of the grafts' rejection. In/C-disparate graft~ 
ings,  Ia antibodies are found in only some combinations and usually can be 
detected only after exposure of the animal to second- or third-set grafts. How- 
ever, we have not excluded the possibility that the Ia antibodies are formed 
against Ia antigens on passenger leukocytes present in the skin (36), and that 
they have nothing to do with the transplantation antigens against which the 
allograft reaction is directed. The second observation is that Ia antigens con- 1450  HISTOCOMPATIBILITY  ANTIGENS 
trolled  by  IA and  IC  subregions are expressed  on epidermal  cells.  The presence 
of  IaA  antigens  on  epidermal  cells  was  first  demonstrated  by  Hiimmerling  et  al. 
(37),  and  we confirm this  finding.  The epidermal-cell  expression  of  IaC antigens 
is  for  the first  time demonstrated in this  communication. The fact  that two to 
three  times  as  many epidermal  cells,  as  compared  with  spleen  cells,  are  needed 
to  absorb  Ia  antibodies  suggests  that  the  concentration  of  Ia  antigens  is  lower  on 
epidermal cells  than on lymphocytes. The third  observation  is  that loci  coding 
for  transplantation  antigens  map in  the  same  I subregions as  the  loci  coding  for 
la antigens.  However, this  last  evidence is not very convincing since  many 
strain  combinations still  have not been tested,  and it is quite  possible  that 
thorough analysis  designed specifically  to  look  for  minor  H  loci  within  the  H-2 
complex will  uncover additional  such loci.  On the other  hand, it  would not be 
surprising  if  the la antigens were to turn out to be also  transplantation  anti- 
gens. After all,  they are expressed on the cell  surface,  and they are part of  a 
histocompatibility  complex. 
Summary 
Skin  grafts  were  reciprocally  exchanged  in  pairs  of  congenic  lines  identical  in 
all  genes except  those  located  in  the central  portion  of  the  H-2 complex. Seven 
such  lines  were  tested:  6R, B10.AQR, A.TL, A.TH, 7R, 9R, and  B10.HTT. In  all 
donor-recipient  combinations at  least  some  grafts  were  rejected.  In  combinations 
differing  at  the  IA subregion (and  other  central  H-2 regions  or  subregions),  all 
first-set  grafts  were rejected  within 3 wk after  transplantation,  and all  second- 
set grafts  were rejected  within 10 days.  In combinations differing  at the IC 
subregion (and other  central  regions,  but not at the  IA subregion)  between 60 
and 100% of  first-set  grafts  were rejected,  but some grafts  survived  for  over  100 
days.  Most  of  the  second-set  grafts  were  rejected  within i  mo after  grafting.  This 
behavior of  skin grafts  indicated  the presence of  two histocompatibility  loci  in 
the  I region,  a strong  one and a weak one.  This conclusion  was confirmed by 
genetic  mapping  which  placed  the  strong  locus  in  the  IA  subregion  and  the  weak 
locus  in  the  IC  subregion.  We designate  the  former  locus  H-2A and  the  latter  H- 
2C. The same strain  combinations  used  for  the skin grafting  were also  used  for 
determination of  the  capacity  ofl-region  antigens  to  function  as  targets  in  the  in 
vitro  cell-mediated  lymphocytotoxicity  (CML) assay.  Spleen  cells  from  mice  pre- 
sensitized  in  vivo  by  skin  grafting  were  restimulated  in  vitro  and  tested  against 
51Cr-labeled  concanavalin A or lipopolysaccharide  blasts.  The testing  revealed 
the  presence in  the  I  region  of  two  loci  coding  for  CML-target antigens.  The  two 
loci  comapped with the  H-2A and  H-2C loci  and were most likely  identical  to 
them. As in  the skin  grafting  test,  in  the CML test,  the H-2A antigens evoked 
stronger  response  than  the  H-2C antigens.  Rejection  of  skin  grafts  across  the  H- 
2A and  H-2C loci  was accompanied by the production of  la antibodies.  Direct 
cytotoxic  and  absorption  tests  with  Ia  antibodies  directed  against  antigens  coded 
for  by  the  IC subregion  revealed  the  presence  of  laC  antigens  on  epidermal  cells. 
We suggest that the products of la loci  might function as transplantation 
antigens. 
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